Literature DB >> 24919954

Comparative study of NMP-preloaded and dip-loaded membranes for guided bone regeneration of rabbit cranial defects.

Lindsay S Karfeld-Sulzer1, Chafik Ghayor1, Barbara Siegenthaler1,2, Bebeka Gjoksi1, Timo H Pohjonen3, Franz E Weber1,2,4.   

Abstract

Guided bone regeneration (GBR) has been utilized for several decades for the healing of cranio-maxillofacial bone defects and, particularly in the dental field, by creating space with a barrier membrane to exclude soft tissue and encourage bone growth in the membrane-protected volume. Although the first membranes were non-resorbable, a new generation of GBR membranes aims to biodegrade and provide bioactivity for better overall results. The Inion GTR™ poly(lactide-co-glycolide) (PLGA) membrane is not only resorbable but also bioactive, since it includes N-methylpyrrolidone (NMP), which has been shown to promote bone regeneration. In this study, the effects of loading different amounts of NMP onto the membrane through chemical vapour deposition or dipping have been explored. In vitro release demonstrated that lower levels of NMP led to lower NMP concentrations and slower release, based on total NMP loaded in the membrane. The dipped membrane released almost all of the NMP within 15 min, leading to a high NMP concentration. For the in vivo studies in rabbits, 6 mm calvarial defects were created and left untreated or covered with an ePTFE membrane or PLGA membranes dipped in, or preloaded with, NMP. Evaluation of the bony regeneration revealed that the barrier membranes improved bony healing and that a decrease in NMP content improved the performance. Overall, we have demonstrated the potential of these PLGA membranes with a more favourable NMP release profile and the significance of exploring the effect of NMP on these PLGA membranes with regard to bone ingrowth.
Copyright © 2014 John Wiley & Sons, Ltd. Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  NMP; PLGA; calvarial defect; guided bone regeneration; membrane

Mesh:

Substances:

Year:  2014        PMID: 24919954     DOI: 10.1002/term.1926

Source DB:  PubMed          Journal:  J Tissue Eng Regen Med        ISSN: 1932-6254            Impact factor:   3.963


  6 in total

1.  N,N Dimethylacetamide a drug excipient that acts as bromodomain ligand for osteoporosis treatment.

Authors:  Chafik Ghayor; Bebeka Gjoksi; Jing Dong; Barbara Siegenthaler; Amedeo Caflisch; Franz E Weber
Journal:  Sci Rep       Date:  2017-02-08       Impact factor: 4.379

2.  Fibrin Hydrogel Based Bone Substitute Tethered with BMP-2 and BMP-2/7 Heterodimers.

Authors:  Lindsay S Karfeld-Sulzer; Barbara Siegenthaler; Chafik Ghayor; Franz E Weber
Journal:  Materials (Basel)       Date:  2015-03-06       Impact factor: 3.623

3.  Effect of N-Vinyl-2-Pyrrolidone (NVP), a Bromodomain-Binding Small Chemical, on Osteoblast and Osteoclast Differentiation and Its Potential Application for Bone Regeneration.

Authors:  Viviane A Klemmer; Nupur Khera; Barbara M Siegenthaler; Indranil Bhattacharya; Franz E Weber; Chafik Ghayor
Journal:  Int J Mol Sci       Date:  2021-10-13       Impact factor: 5.923

4.  ETV2 promotes osteogenic differentiation of human dental pulp stem cells through the ERK/MAPK and PI3K-Akt signaling pathways.

Authors:  Jing Li; Haoran Du; Xin Ji; Yihan Chen; Yishuai Li; Boon Chin Heng; Jianguang Xu
Journal:  Stem Cell Res Ther       Date:  2022-10-04       Impact factor: 8.079

5.  Osteoconductive Microarchitecture of Bone Substitutes for Bone Regeneration Revisited.

Authors:  Chafik Ghayor; Franz E Weber
Journal:  Front Physiol       Date:  2018-07-19       Impact factor: 4.566

6.  The Release of the Bromodomain Ligand N,N-Dimethylacetamide Adds Bioactivity to a Resorbable Guided Bone Regeneration Membrane in a Rabbit Calvarial Defect Model.

Authors:  Barbara Siegenthaler; Chafik Ghayor; Nisarat Ruangsawasdi; Franz E Weber
Journal:  Materials (Basel)       Date:  2020-01-21       Impact factor: 3.623

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.